EFFECT OF ARFORMOTEROL TWICE DAILY, TIOTROPIUM ONCE DAILY, AND THEIR COMBINATION IN SUBJECTS WITH COPD

Chest(2008)

Cited 1|Views6
No score
Abstract
PURPOSE: Previous studies in subjects with COPD suggest that combined therapy with inhaled β2-agonist and anticholinergics provide increased bronchodilation compared with monotherapies. This was a 2-week, multi-center, randomized, parallel group study designed to evaluate the efficacy and safety of concomitant treatment with nebulized arformoterol (the R,R-isomer of formoterol) and tiotropium DPI.
More
Translated text
Key words
COPD,Aerosol Therapy,Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined